You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease

Citation Tools

Article menu

Download PDFPDF

XML
Interstitial lung disease
Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Flaherty KR, Brown KK, Wells AU, et al
Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease
BMJ Open Respiratory Research 2017;4:e000212. doi: 10.1136/bmjresp-2017-000212